HDAC inhibition prevents NF-kappa B activation by suppressing proteasome activity: down-regulation of proteasome subunit expression stabilizes I kappa B alpha - PubMed (original) (raw)
Comparative Study
. 2005 Aug 1;70(3):394-406.
doi: 10.1016/j.bcp.2005.04.030.
Affiliations
- PMID: 15950952
- DOI: 10.1016/j.bcp.2005.04.030
Comparative Study
HDAC inhibition prevents NF-kappa B activation by suppressing proteasome activity: down-regulation of proteasome subunit expression stabilizes I kappa B alpha
Robert F Place et al. Biochem Pharmacol. 2005.
Abstract
The short chain fatty acid (SCFA) butyrate (BA) and other histone deacetylase (HDAC) inhibitors can rapidly induce cell cycle arrest and differentation of colon cancer cell lines. We found that butyrate and the specific HDAC inhibitor trichostatin A (TSA) can reprogram the NF-(kappa)B response in colon cancer cells. Specifically, TNF-alpha activation is suppressed in butyrate-differentiated cells, whereas IL-1beta activation is largely unaffected. To gain insight into the relationship between butyrate-induced differentiation and NF-(kappa)B regulation, we determined the impact of butyrate on proteasome activity and subunit expression. Interestingly, butyrate and TSA reduced the cellular proteasome activity in colon cancer cell lines. The drop in proteasome activity results from the reduced expression of the catalytic beta-type subunits of the proteasome at both the protein and mRNA level. The selective impact of HDAC inhibitors on TNF-alpha-induced NF-(kappa)B activation appears to relate to the fact that the TNF-alpha-induced activation of NF-(kappa)B is mediated by the proteasome, whereas NF-kappaB activation by IL-1beta is largely proteasome-independent. These findings indicate that cellular differentation status and/or proliferative capacity can significantly impact proteasome activity and selectively alter NF-(kappa)B responses in colon cancer cells. This information may be useful for the further development and targeting of HDAC inhibitors as anti-neoplastic and anti-inflammatory agents.
Similar articles
- Butyrate suppression of colonocyte NF-kappa B activation and cellular proteasome activity.
Yin L, Laevsky G, Giardina C. Yin L, et al. J Biol Chem. 2001 Nov 30;276(48):44641-6. doi: 10.1074/jbc.M105170200. Epub 2001 Sep 25. J Biol Chem. 2001. PMID: 11572859 - Potentiation of tumor necrosis factor-induced NF-kappa B activation by deacetylase inhibitors is associated with a delayed cytoplasmic reappearance of I kappa B alpha.
Adam E, Quivy V, Bex F, Chariot A, Collette Y, Vanhulle C, Schoonbroodt S, Goffin V, Nguyên TL, Gloire G, Carrard G, Friguet B, De Launoit Y, Burny A, Bours V, Piette J, Van Lint C. Adam E, et al. Mol Cell Biol. 2003 Sep;23(17):6200-9. doi: 10.1128/MCB.23.17.6200-6209.2003. Mol Cell Biol. 2003. PMID: 12917341 Free PMC article. - Inactivation of NF-kappaB by proteasome inhibition contributes to increased apoptosis induced by histone deacetylase inhibitors in human breast cancer cells.
Domingo-Domènech J, Pippa R, Tápia M, Gascón P, Bachs O, Bosch M. Domingo-Domènech J, et al. Breast Cancer Res Treat. 2008 Nov;112(1):53-62. doi: 10.1007/s10549-007-9837-8. Epub 2007 Dec 6. Breast Cancer Res Treat. 2008. PMID: 18064564 - The Ubiquitin-Proteasome Pathway and Epigenetic Modifications in Cancer.
Yerlikaya A, Kanbur E, Stanley BA, Tümer E. Yerlikaya A, et al. Anticancer Agents Med Chem. 2021;21(1):20-32. doi: 10.2174/1871520620666200811114159. Anticancer Agents Med Chem. 2021. PMID: 32781973 Review. - Histone deacetylase 3 (HDAC 3) as emerging drug target in NF-κB-mediated inflammation.
Leus NG, Zwinderman MR, Dekker FJ. Leus NG, et al. Curr Opin Chem Biol. 2016 Aug;33:160-8. doi: 10.1016/j.cbpa.2016.06.019. Epub 2016 Jun 29. Curr Opin Chem Biol. 2016. PMID: 27371876 Free PMC article. Review.
Cited by
- ITF2357 regulates NF-κB signaling pathway to protect barrier integrity in retinal pigment epithelial cells.
Lim RR, Mahaling B, Tan A, Mehta M, Kaur C, Hunziker W, Kim JE, Barathi VA, Ghosh A, Chaurasia SS. Lim RR, et al. FASEB J. 2024 Mar 15;38(5):e23512. doi: 10.1096/fj.202301592R. FASEB J. 2024. PMID: 38430220 - HDACs and the senescent phenotype of WI-38 cells.
Place RF, Noonan EJ, Giardina C. Place RF, et al. BMC Cell Biol. 2005 Oct 26;6:37. doi: 10.1186/1471-2121-6-37. BMC Cell Biol. 2005. PMID: 16250917 Free PMC article. - Piperlongumine regulates epigenetic modulation and alleviates psoriasis-like skin inflammation via inhibition of hyperproliferation and inflammation.
Thatikonda S, Pooladanda V, Sigalapalli DK, Godugu C. Thatikonda S, et al. Cell Death Dis. 2020 Jan 10;11(1):21. doi: 10.1038/s41419-019-2212-y. Cell Death Dis. 2020. PMID: 31924750 Free PMC article. - Steering Endogenous Butyrate Production in the Intestinal Tract of Broilers as a Tool to Improve Gut Health.
Onrust L, Ducatelle R, Van Driessche K, De Maesschalck C, Vermeulen K, Haesebrouck F, Eeckhaut V, Van Immerseel F. Onrust L, et al. Front Vet Sci. 2015 Dec 17;2:75. doi: 10.3389/fvets.2015.00075. eCollection 2015. Front Vet Sci. 2015. PMID: 26734618 Free PMC article. Review. - Prediction of histone deacetylase inhibition by triazole compounds based on artificial intelligence.
Wang Y, Zhang P. Wang Y, et al. Front Pharmacol. 2023 Nov 15;14:1260349. doi: 10.3389/fphar.2023.1260349. eCollection 2023. Front Pharmacol. 2023. PMID: 38035010 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials